Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Pàgina 1 des de 18 resultats
Isolated human inositol polyphosphate 5-phosphatase
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD OF THE INVENTION
The invention relates to the area of enzyme regulation. More particularly, the invention relates to the regulation of human inositol polyphosphate 5-phosphatase.
BACKGROUND OF THE INVENTION
SHC and GRB2 protein signaling molecules form a complex in response to growth
Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention is directed to compositions and methods for using the mixed calcium/sodium salt of inositol-tripyrophosphate (ITPP-Ca/Na) to enhance oxygen delivery by red blood cells. ITPP-Ca/Na is an allosteric effector of hemoglobin which has the ability to cross the
Method of treating angiogenesis in tumor tissue
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The present invention relates to a method of treating angionesis in tumor tissue, which method comprises administering an isomer of inositoltrisphosphate (IP.sub.3) or a pharmaceutically acceptable salt thereof.
Even as early as the year 1900, different researchers had reported the finding of the
Combination treatment of cancer
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a US National Phase filing of PCT/EP2013/068120, filed on Sep. 2, 2013, which claims priority of 12183618.3 (EP), filed on Sep. 7, 2012, the entire disclosures of which are hereby expressly incorporated by reference.
The present invention
Inhibitors of phosphatidyl myo-inositol cycle
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to specific compounds designed to inhibit cell growth signaling. In particular, PtdIns-3-kinase anti-metabolites are rationally designed to provide compounds that inhibit cell differentiation and/or cell
Inhibitors of phosphatidyl myo-inositol cycle
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to specific compounds designed to inhibit cell growth signaling. In particular, PtdIns-3-kinase anti-metabolites are rationally designed to provide compounds that inhibit cell differentiation and/or cell
Tryptamine-based ship inhibitors for the treatment of cancer
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE DISCLOSURE
Colorectal cancer (CRC) is the second most common malignancy in women and the third most common malignancy in men worldwide (1). Although CRC mortality has been declining due to improvements in screening techniques and CRC treatment, it is still the second most common
Metal complex phosphatidyl-inositol-3-kinase inhibitors
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present application pertains to metal complex protein kinases inhibitors, methods for making such compounds, and methods for using such compounds for treating diseases and disorders mediated by kinase activity.
BACKGROUND OF THE INVENTION
The development of small molecules
Inhibitors of human phosphatidyl-inositol 3-kinase delta
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The present invention relates generally to phosphatidylinositol 3-kinase (PI3K) enzymes, and more particularly to selective inhibitors of PI3K activity and to methods of using such materials.
BACKGROUND OF THE INVENTION
Cell signaling via 3'-phosphorylated phosphoinositides
Malaria treatments
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This application is a 371 of PCT/GB93/00084 filed Jan. 1, 1993.
The present invention relates to the treatment and prevention of malaria and certain other infectious diseases, especially to materials for use in such treatment and prevention.
Malaria is caused by organisms of the genus Plasmodium
Reduction of cell proliferation and enhancement of NK-cell activity
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
DESCRIPTION OF THE INVENTION 1. Technical Field of the Invention
This invention relates to compositions comprising a mixture of inositol (I) and inositol hexaphosphate (IP.sub.6) and their use in normalizing the rate of mitosis sensitive to treatment with a solution below in mammalian tissues
Neuropeptide antagonists
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
This invention relates to antagonists to various receptors for neuropeptides, in particular to antagonists that are non-structural analogues of the specific mitogenic neuropeptide ligand. Neuropeptides are increasingly implicated in the control of cell proliferation.sup.1. The amphibian
Certain chemical entities, compositions and methods
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND OF THE INVENTION
The activity of cells can be regulated by external signals that stimulate or inhibit intracellular events. The process by which stimulatory or inhibitory signals are transmitted into and within a cell to elicit an intracellular response is referred to as signal
Phosphonates as anti-inflammation agents
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
This invention pertains to the synthesis and use as therapeutic agents of a group of substances with a glycerol backbone or aliphatic chain structure linked to phosphonocholine, phosphinocholine, phosphonoinositol, phosphinoinositol, or other phosphorus-containing head groups.
Method for determining modulation of P110.DELTA. activity
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
The invention relates to a novel lipid kinase which is part of the PI3 Kinase (PI3K) family and more specifically the invention relates to various aspects of the novel lipid kinase particularly, but not exclusively, to an identification of expression of said kinase with a view to diagnosing or
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
